MLABMesa Laboratories, Inc.
Price
+86%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality strong, nothing alarming, price roughly fair, growth steady, the market with it.
Charts
As reported to the SEC, without any scoring.
Mesa Laboratories, Inc. (MLAB) reported revenue of $60M in Q1 2027 (quarter ended Jun 30, 2026), up 1.0% from the same quarter a year earlier. That came with a gross margin of 65% and net income of $2.8M (4.7% of revenue). For the full year FY2026, revenue was $249M (+3.4% year on year) and net income $6.7M. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Jul 30, 2026On July 30, 2026, the Board of Directors of Mesa Laboratories, Inc. (the "Company") approved an amended and restated Code of Ethics and Business Conduct (the "Code"), effective immediately.Code-of-ethics amendment or waiver · Form 8-K
- Jun 15, 2026On June 11, 2026, the board of directors (the “Board”) of Mesa Laboratories, Inc. (“Mesa” or the “Company”) approved the appointment of Lyndsey Crennen as the Chief Accounting Officer of the Company, effective as of her entry into the Employment Agreement described below.Director or officer change · Form 8-K
- Mar 23, 2026On March 9, 2026, Mesa Laboratories, Inc. (“Mesa” or the “Company”) announced the departure of Gary Owens as President and Chief Executive Officer of the Company, effective on or about April 13, 2026.Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Scientific & Technical Instruments
Ranks #11 of 12 by RyuScore